User profiles for MacKenzie Horn
MacKenzie HornUniversity of Calgary Verified email at ucalgary.ca Cited by 437 |
Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised …
Background Intravenous thrombolysis with alteplase bolus followed by infusion is a global
standard of care for patients with acute ischaemic stroke. We aimed to determine whether …
standard of care for patients with acute ischaemic stroke. We aimed to determine whether …
Safety and efficacy of tenecteplase compared with alteplase in patients with large vessel occlusion stroke: a prespecified secondary analysis of the ACT randomized …
…, G Hunter, I Alhabli, F Benali, MK Horn… - JAMA …, 2023 - jamanetwork.com
Importance It is unknown whether intravenous thrombolysis using tenecteplase is noninferior
or preferable compared with alteplase for patients with acute ischemic stroke. Objective To …
or preferable compared with alteplase for patients with acute ischemic stroke. Objective To …
Thrombus migration and fragmentation after intravenous alteplase treatment: the INTERRSeCT study
Background and Purpose: There is interest in what happens over time to the thrombus after
intravenous alteplase. We study the effect of alteplase on thrombus structure and its impact …
intravenous alteplase. We study the effect of alteplase on thrombus structure and its impact …
Automated perfusion calculations vs. visual scoring of collaterals and CBV-ASPECTS: has the machine surpassed the eye?
Purpose Use of automated perfusion software has gained importance for imaging of stroke
patients for mechanical thrombectomy (MT). We aim to compare four perfusion software …
patients for mechanical thrombectomy (MT). We aim to compare four perfusion software …
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial
Background Individuals with minor ischaemic stroke and intracranial occlusion are at
increased risk of poor outcomes. Intravenous thrombolysis with tenecteplase might improve …
increased risk of poor outcomes. Intravenous thrombolysis with tenecteplase might improve …
Non-invasive brain temperature measurement in acute ischemic stroke
Selective therapeutic hypothermia in the setting of mechanical thrombectomy (MT) is promising
to further improve the outcomes of large vessel occlusion stroke. A significant limitation in …
to further improve the outcomes of large vessel occlusion stroke. A significant limitation in …
The treatment effect across ASPECTS in acute ischemic stroke: Analysis from the AcT trial
Background: Early ischemic changes on baseline imaging are commonly evaluated for
acute stroke decision-making and prognostication. Aims: We assess the association of early …
acute stroke decision-making and prognostication. Aims: We assess the association of early …
Timing of Spot Sign Appearance, Spot Sign Volume, and Leakage Rate among Phases of Multiphase CTA Predict Intracerebral Hemorrhage Growth
BACKGROUND AND PURPOSE: The presence of spot sign is associated with a high risk of
hematoma growth. Our aim was to investigate the timing of the appearance, volume, and …
hematoma growth. Our aim was to investigate the timing of the appearance, volume, and …
Safety and efficacy of tenecteplase versus alteplase in stroke patients with carotid tandem lesions: Results from the AcT trial
…, G Hunter, F Benali, MK Horn… - … Journal of Stroke, 2024 - journals.sagepub.com
Background: Carotid tandem lesions ((TL) ⩾70% stenosis or occlusion) account for 15–20%
of acute stroke with large vessel occlusion. Aims: We investigated the safety and efficacy of …
of acute stroke with large vessel occlusion. Aims: We investigated the safety and efficacy of …
Total intracranial hemorrhage volume measurement summating all compartments best in traumatic and nontraumatic intracranial bleeding
Background and purpose The ANNEXA‐4 trial measured hemostatic efficacy of andexanet
alfa in patients with major bleeding taking factor Xa inhibitors. A proportion of this was …
alfa in patients with major bleeding taking factor Xa inhibitors. A proportion of this was …